Related references
Note: Only part of the references are listed.Effects of statins on the biological features of mesenchymal stem cells and therapeutic implications
Armita Mahdavi Gorabi et al.
HEART FAILURE REVIEWS (2021)
Novel biomarkers associated with incident heart failure in 10 106 Finnish men
Raimo Jauhiainen et al.
ESC HEART FAILURE (2021)
Lipid Lowering Drugs: Present Status and Future Developments
Massimiliano Ruscica et al.
CURRENT ATHEROSCLEROSIS REPORTS (2021)
Red Yeast Rice for Hypercholesterolemia JACC Focus Seminar
Arrigo F. G. Cicero et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)
Therapeutic Lowering of C-Reactive Protein
Rachel V. Jimenez et al.
FRONTIERS IN IMMUNOLOGY (2021)
Improved COVID-19 ICU admission and mortality outcomes following treatment with statins: a systematic review and meta-analysis
Amir Vahedian-Azimi et al.
Archives of Medical Science (2021)
New and Emerging Therapies for Reduction of LDL-Cholesterol and Apolipoprotein B
Nick S. Nurmohamed et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)
Hydrophilic or Lipophilic Statins?
Elisenda Climent et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)
Statins as anti-pyroptotic agents
Masoomeh Khalifeh et al.
ARCHIVES OF MEDICAL SCIENCE (2021)
Implications on the Therapeutic Potential of Statins via Modulation of Autophagy
Armita Mahdavi Gorabi et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2021)
Effect of resveratrol on C-reactive protein: An updated meta-analysis of randomized controlled trials
Armita Mahdavi Gorabi et al.
PHYTOTHERAPY RESEARCH (2021)
A systematic review and meta-analysis on the efficacy of statins in the treatment of atherosclerosis
Jianpu Jia et al.
ANNALS OF PALLIATIVE MEDICINE (2021)
Effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on ageing: Molecular mechanisms
Afsane Bahrami et al.
AGEING RESEARCH REVIEWS (2020)
Efficacy and safety of bempedoic acid for the treatment of hypercholesterolemia: A systematic review and meta-analysis
Arrigo F. G. Cicero et al.
PLOS MEDICINE (2020)
Statins and C-reactive protein: in silico evidence on direct interaction
Neda Shakour et al.
ARCHIVES OF MEDICAL SCIENCE (2020)
Statins and the COVID-19 main protease: in silico evidence on direct interaction
Zeljko Reiner et al.
ARCHIVES OF MEDICAL SCIENCE (2020)
Mast cell tryptase - Marker and maker of cardiovascular diseases
Mohammad Mohajeri et al.
PHARMACOLOGY & THERAPEUTICS (2019)
Clinical efficacy and safety of statin treatment after carotid artery stenting
Lingya Qiao et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2019)
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol
Scott M. Grundy et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Preoperative statins as modifiers of cardiac and inflammatory outcomes following coronary artery bypass graft surgery: a meta-analysis
JingHui An et al.
INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY (2017)
EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries
Kornelia Kotseva et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2016)
Clinical relevance for lowering C-reactive protein with statins
Jose Carlos Arevalo-Lorido
ANNALS OF MEDICINE (2016)
Impact of statin therapy on plasma adiponectin concentrations: A systematic review and meta-analysis of 43 randomized controlled trial arms
Piotr Chrusciel et al.
ATHEROSCLEROSIS (2016)
The impact of statin therapy on plasma levels of von Willebrand factor antigen Systematic review and meta-analysis of randomised placebo-controlled trials
Amirhossein Sahebkar et al.
THROMBOSIS AND HAEMOSTASIS (2016)
Atorvastatin Therapy Modulates Telomerase Activity in Patients Free of Atherosclerotic Cardiovascular Diseases
Irina D. Strazhesko et al.
FRONTIERS IN PHARMACOLOGY (2016)
Early Effects of Treatment Low-Dose Atorvastatin on Markers of Insulin Resistance and Inflammation in Patients with Myocardial Infarction
Olga Gruzdeva et al.
FRONTIERS IN PHARMACOLOGY (2016)
Statin therapy reduces plasma endothelin-1 concentrations: A meta-analysis of 15 randomized controlled trials
Amirhossein Sahebkar et al.
ATHEROSCLEROSIS (2015)
Efficacy and Safety of Loading-Dose Rosuvastatin Therapy in Elderly Patients with Acute Coronary Syndromes Undergoing Elective Percutaneous Coronary Intervention
Yungen Jiao et al.
CLINICAL DRUG INVESTIGATION (2015)
Effect of statin therapy on paraoxonase-1 status: A systematic review and meta-analysis of 25 clinical trials
Gianna Ferretti et al.
PROGRESS IN LIPID RESEARCH (2015)
Association between statin use and plasma D-dimer levels
Amirhossein Sahebkar et al.
THROMBOSIS AND HAEMOSTASIS (2015)
Cardiovascular effects of statins, beyond lipid-lowering properties
Christos G. Mihos et al.
PHARMACOLOGICAL RESEARCH (2014)
C-Reactive Protein: Clinical and Epidemiological Perspectives
Juan Salazar et al.
CARDIOLOGY RESEARCH AND PRACTICE (2014)
New Therapies Targeting apoB Metabolism for High-Risk Patients with Inherited Dyslipidaemias: What Can the Clinician Expect?
Amirhossein Sahebkar et al.
CARDIOVASCULAR DRUGS AND THERAPY (2013)
New LDL-Cholesterol Lowering Therapies: Pharmacology, Clinical Trials, and Relevance to Acute Coronary Syndromes
Amirhossein Sahebkar et al.
CLINICAL THERAPEUTICS (2013)
High-sensitivity C-reactive protein and atherosclerotic disease: From improved risk prediction to risk-guided therapy
Wolfgang Koenig
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Effects of Statin Therapy on the Production of Monocyte Pro-Inflammatory Cytokines, Cardiac Function, and Long-Term Prognosis in Chronic Heart Failure Patients With Dyslipidemia
Akihiro Nakagomi et al.
CIRCULATION JOURNAL (2012)
Long-Term Statin Therapy in Patients With Systolic Heart Failure and Normal Cholesterol: Effects on Elevated Serum Markers of Collagen Turnover, Inflammation, and B-Type Natriuretic Peptide
Esam Abulhul et al.
CLINICAL THERAPEUTICS (2012)
Effects of atorvastatin on serum lipids, serum inflammation and plaque morphology in patients with stable atherosclerotic plaques
Suxia Guo et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2012)
Simvastatin Therapy Reduces Prooxidant-Antioxidant Balance: Results of a Placebo-Controlled Cross-Over Trial
Seyyed M. R. Parizadeh et al.
LIPIDS (2011)
Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey
Richard Kones
DRUG DESIGN DEVELOPMENT AND THERAPY (2011)
Effect of Previous Statin Therapy in Patients With Acute Coronary Syndrome and Percutaneous Coronary Intervention
Kyeong Ho Yun et al.
KOREAN CIRCULATION JOURNAL (2011)
Comparison of Clinical Outcomes of Hydrophilic and Lipophilic Statins in Patients with Acute Myocardial Infarction
Min Chul Kim et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2011)
Early intensive statin treatment for six months improves long-term clinical outcomes in patients with acute coronary syndrome (Extended-ESTABLISH trial): A follow-up study
Tomotaka Dohi et al.
ATHEROSCLEROSIS (2010)
Meta-Analysis of Randomized Controlled Trials of Statins Versus Placebo in Patients With Heart Failure
Michael J. Lipinski et al.
AMERICAN JOURNAL OF CARDIOLOGY (2009)
C-reactive protein impairs the endothelial glycocalyx resulting in endothelial dysfunction
Sridevi Devaraj et al.
CARDIOVASCULAR RESEARCH (2009)
Statins and Cardiovascular Diseases: From Cholesterol Lowering to Pleiotropy
Qian Zhou et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
The beneficial effect of high loading dose of rosuvastatin before percutaneous coronary intervention in patients with acute coronary syndrome
Kyeong Ho Yun et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2009)
Diversity of denizens of the atherosclerotic plaque - Not all monocytes are created equal
Peter Libby et al.
CIRCULATION (2008)
Atorvastatin administration after percutaneous coronary intervention in patients with coronary artery disease and normal lipid profiles: Impact on plasma adiponectin level
Kuei-Chuan Chan et al.
CLINICAL CARDIOLOGY (2008)
Atorvastatin-Induced Changes in Plasma Coenzyme Q10 and Brain Natriuretic Peptide in Patients With Coronary Artery Disease
Takayuki Suzuki et al.
INTERNATIONAL HEART JOURNAL (2008)
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Paul M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention - Results of the ARMYDA-ACS randomized trial
Giuseppe Patti et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Reduction of C-reactive protein by a single 80 mg of sirnvastatin in patients with unstable angina
Jian-Jun Li et al.
CLINICA CHIMICA ACTA (2007)
Rapid immunomodulation by rosuvastatin in patients with acute coronary syndrome
Andreas Link et al.
EUROPEAN HEART JOURNAL (2006)
Clinical relevance of C-reactive protein during follow-up of patients with acute coronary syndromes in the Aggrastat-to-Zocor Trial
David A. Morrow et al.
CIRCULATION (2006)
Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease
Carlos M. Ferrario et al.
AMERICAN JOURNAL OF CARDIOLOGY (2006)
Effects of statins beyond lipid lowering: Potential for clinical benefits
K Almuti et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2006)
C-reactive protein induces matrix metalloproteinase-1 and-10 in human endothelial cells -: Implications for clinical and subclinical atherosclerosis
I Montero et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure
S Sola et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Reduction of soluble P-selectin by statins is inversely correlated with the progression of coronary artery disease
P Marschang et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2006)
The effect of different doses of fluvastatin on inflammatory markers in the early phase of acute coronary syndrome
Jun Yang et al.
CLINICA CHIMICA ACTA (2006)
Effects of 4 weeks of atorvastatin administration on the antiinflammatory cytokine interleukin-10 in patients with unstable angina
JJ Li et al.
CLINICAL CHEMISTRY (2005)
Atorvastatin has an important acute anti-inflammatory effect in patients with acute coronary syndrome:: Results of a randomized, double-blind, placebo-controlled study
SM Macin et al.
AMERICAN HEART JOURNAL (2005)
Effect of preexisting statin use on expression of C-reactive protein, adhesion molecules, interleukin-6, and antioxidized low-density lipoprotein antibody in patients with unstable angina undergoing coronary stenting
YC Doo et al.
CLINICAL CARDIOLOGY (2005)
Effects of Tirofiban and statins on high-sensitivity c-reactive protein, interleukin-6, and soluble CD40 ligand following percutaneous coronary interventions in patients with stable coronary artery disease
RR Azar et al.
AMERICAN JOURNAL OF CARDIOLOGY (2005)
C-reactive protein levels and outcomes after statin therapy
PM Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Use of statins and fracture - Results of 4 prospective studies and cumulative meta-analysis of observational studies and controlled trials
DC Bauer et al.
ARCHIVES OF INTERNAL MEDICINE (2004)
Changes in serum interleukin-6 and high-sensitivity C-reactive protein levels in patients with acute coronary syndrome and their responses to simvastatin
YM Luo et al.
HEART AND VESSELS (2004)
Effects of statins on nonlipid serum markers associated with cardiovascular disease - A systematic review
EM Balk et al.
ANNALS OF INTERNAL MEDICINE (2003)
High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study
S Kinlay et al.
CIRCULATION (2003)
Short-term statin therapy improves cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy
K Node et al.
CIRCULATION (2003)
Relation of statin use to the 5-year incidence and progression of age-related maculopathy
R Klein et al.
ARCHIVES OF OPHTHALMOLOGY (2003)
Anti-inflammatory effect of Atorvastatin (80 mg) in unstable angina pectoris and non-Q-wave acute myocardial infarction
LCL Correia et al.
AMERICAN JOURNAL OF CARDIOLOGY (2003)
The effect of early treatment by cerivastatin on the serum level of C-reactive protein, interleukin-6, and interleukin-8 in the patients with unstable angina and non-Q-wave myocardial infarction
P Ostadal et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2003)
HMG-CoA reductase inhibitor ameliorates diabetic nephropathy by its pleiotropic effects in rats
H Usui et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2003)
A novel anti-inflammatory role for simvastatin in inflammatory arthritis
BP Leung et al.
JOURNAL OF IMMUNOLOGY (2003)
Atorvastatin affects C-reactive protein levels in patients with coronary artery disease
I Karaca et al.
CURRENT MEDICAL RESEARCH AND OPINION (2003)
Simvastatin inhibits inflammatory properties of Staphylococcus aureus α-toxin
D Pruefer et al.
CIRCULATION (2002)
Quantifying heterogeneity in a meta-analysis
JPT Higgins et al.
STATISTICS IN MEDICINE (2002)
Statins and cardiovascular diseases: the multiple effects of lipid-lowering therapy by statins
U Rauch et al.
ATHEROSCLEROSIS (2000)
Neuroprotection mediated by changes in the endothelial actin cytoskeleton
U Laufs et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Share Paper
